Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research focused on Breast cancer and Gene knockdown, with related work in Carcinogenesis, Cancer research, Wnt signaling pathway. Notable publications include 'miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1', 'Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile', and 'Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis'.
Brain Connectomics Improve the Prediction of High-Risk Depression Profiles in the First Year following Breast Cancer Diagnosis
Associations Between Brain Structural Connectivity and 1‐Year Demoralization in Breast Cancer: A Longitudinal Diffusion Tensor Imaging Study
The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review
Multi-omics analysis reveals the prognostic and tumor micro-environmental value of lumican in multiple cancer types
Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan‐cancer analysis
Development and validation of an immune‐related gene signature for prognosis in Lung adenocarcinoma
Measurement invariance of the 10-item resilience scale specific to cancer in Americans and Chinese: A propensity score–based multidimensional item response theory analysis
Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis
LncRNA FOXC2 antisense transcript accelerates non-small-cell lung cancer tumorigenesis via silencing p15.
PubMed 2019cited by 16position: first
Jinfu’an Decoction Inhibits Invasion and Metastasis in Human Lung Cancer Cells (H1650) via p120ctn-Mediated Induction and Kaiso
Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile
miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1